NEW YORK – Newborn and pediatric testing company Baebies said on Wednesday that its newborn screening assays for galactosemia and biotinidase deficiency have received the CE mark and are available in Europe and other geographies that recognize the CE mark.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.